nodes	percent_of_prediction	percent_of_DWPC	metapath
Buclizine—Imatinib—NQO2—Parkinson's disease	0.045	0.232	CrCbGaD
Buclizine—Imatinib—ABL1—Parkinson's disease	0.0237	0.122	CrCbGaD
Buclizine—Fluspirilene—HTR1A—Parkinson's disease	0.0119	0.0616	CrCbGaD
Buclizine—CHRM1—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.0105	0.013	CbGpPWpGaD
Buclizine—Fluspirilene—DRD2—Parkinson's disease	0.0101	0.0523	CrCbGaD
Buclizine—Clemastine—CYP2D6—Parkinson's disease	0.0101	0.0523	CrCbGaD
Buclizine—Hydroxyzine—CYP2D6—Parkinson's disease	0.00995	0.0513	CrCbGaD
Buclizine—Bifonazole—CYP2E1—Parkinson's disease	0.00984	0.0507	CrCbGaD
Buclizine—HRH1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.00962	0.0119	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.00958	0.0119	CbGpPWpGaD
Buclizine—HRH1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.00922	0.0114	CbGpPWpGaD
Buclizine—CHRM1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.00919	0.0114	CbGpPWpGaD
Buclizine—CHRM1—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00871	0.0108	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.0086	0.0107	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.00857	0.0106	CbGpPWpGaD
Buclizine—Azelastine—CYP2E1—Parkinson's disease	0.00809	0.0417	CrCbGaD
Buclizine—Fluspirilene—HTR2A—Parkinson's disease	0.00784	0.0404	CrCbGaD
Buclizine—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00775	0.00962	CbGpPWpGaD
Buclizine—CHRM1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00773	0.00959	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00743	0.00922	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00741	0.00919	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.00729	0.00904	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.00726	0.00901	CbGpPWpGaD
Buclizine—Fexofenadine—CYP2D6—Parkinson's disease	0.00703	0.0362	CrCbGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00652	0.00809	CbGpPWpGaD
Buclizine—Cinnarizine—DRD2—Parkinson's disease	0.0065	0.0335	CrCbGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.0065	0.00806	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00637	0.0079	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00635	0.00787	CbGpPWpGaD
Buclizine—Imatinib—CYP2D6—Parkinson's disease	0.00613	0.0316	CrCbGaD
Buclizine—Azelastine—CYP2D6—Parkinson's disease	0.00594	0.0306	CrCbGaD
Buclizine—Flunarizine—CYP2D6—Parkinson's disease	0.00581	0.03	CrCbGaD
Buclizine—CHRM1—Circadian rythm related genes—DDC—Parkinson's disease	0.00565	0.007	CbGpPWpGaD
Buclizine—CHRM1—Regulation of Actin Cytoskeleton—FGF20—Parkinson's disease	0.00552	0.00685	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.00527	0.00654	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.00525	0.00652	CbGpPWpGaD
Buclizine—Fexofenadine—ABCB1—Parkinson's disease	0.00502	0.0259	CrCbGaD
Buclizine—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	0.00485	0.00602	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—GPR37—Parkinson's disease	0.00483	0.006	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00471	0.00585	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.0047	0.00583	CbGpPWpGaD
Buclizine—Cinnarizine—CYP2D6—Parkinson's disease	0.00459	0.0237	CrCbGaD
Buclizine—Loperamide—CYP2D6—Parkinson's disease	0.00447	0.0231	CrCbGaD
Buclizine—Imatinib—ABCB1—Parkinson's disease	0.00438	0.0226	CrCbGaD
Buclizine—Azelastine—ABCB1—Parkinson's disease	0.00424	0.0219	CrCbGaD
Buclizine—CHRM1—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.00421	0.00523	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.0041	0.00509	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00409	0.00507	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00383	0.00475	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00382	0.00473	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00375	0.00466	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00374	0.00464	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—DRD1—Parkinson's disease	0.00353	0.00438	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00346	0.0043	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00345	0.00428	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00342	0.00425	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—DRD3—Parkinson's disease	0.00342	0.00424	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00341	0.00423	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00339	0.00421	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00338	0.0042	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	0.0033	0.00409	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—GRM4—Parkinson's disease	0.00329	0.00408	CbGpPWpGaD
Buclizine—Loperamide—ABCB1—Parkinson's disease	0.00319	0.0165	CrCbGaD
Buclizine—CHRM1—Circadian rythm related genes—TH—Parkinson's disease	0.00315	0.00391	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—PENK—Parkinson's disease	0.00312	0.00388	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—PENK—Parkinson's disease	0.00311	0.00386	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—DRD2—Parkinson's disease	0.00309	0.00384	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—HTR7—Parkinson's disease	0.00309	0.00384	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00304	0.00377	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00303	0.00375	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.003	0.00373	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00299	0.00372	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00297	0.00368	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00296	0.00367	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.0029	0.0036	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00289	0.00359	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	0.00286	0.00355	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—PDYN—Parkinson's disease	0.00285	0.00353	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00281	0.00349	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.0028	0.00348	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00274	0.0034	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00273	0.00339	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	0.00266	0.0033	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—GRM5—Parkinson's disease	0.00265	0.00329	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00263	0.00327	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00262	0.00326	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00257	0.00319	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00257	0.00318	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00254	0.00315	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00254	0.00315	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00254	0.00315	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00253	0.00314	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00253	0.00314	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00253	0.00314	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	0.00249	0.00309	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00249	0.00309	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00249	0.00308	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00248	0.00308	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.00248	0.00308	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00248	0.00307	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00241	0.00299	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.0024	0.00298	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00235	0.00292	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00235	0.00291	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.0023	0.00286	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.0023	0.00285	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00228	0.00282	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00227	0.00281	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00226	0.0028	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00225	0.00279	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00218	0.0027	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00218	0.0027	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00217	0.00269	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00217	0.00269	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00208	0.00258	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00207	0.00257	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00206	0.00256	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00205	0.00255	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00196	0.00243	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00195	0.00242	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	0.00193	0.0024	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00192	0.00239	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	0.00189	0.00235	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.00189	0.00234	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	0.00189	0.00234	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.00188	0.00233	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00186	0.00231	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00186	0.0023	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	0.00183	0.00227	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00183	0.00227	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00178	0.00221	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00177	0.0022	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	0.00177	0.0022	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00177	0.00219	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	0.00177	0.00219	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00176	0.00218	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00174	0.00216	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00174	0.00216	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	0.00169	0.0021	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00169	0.00209	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	0.00166	0.00206	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	0.00166	0.00206	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00165	0.00205	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00165	0.00205	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00162	0.002	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00161	0.002	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	0.0016	0.00199	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	0.0016	0.00198	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00153	0.00189	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00152	0.00189	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0015	0.00186	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0015	0.00186	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.00146	0.00181	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	0.00136	0.00169	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.00136	0.00169	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00134	0.00167	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00134	0.00166	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	0.00133	0.00165	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.00132	0.00164	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00128	0.00158	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00127	0.00158	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.00118	0.00146	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	0.00118	0.00146	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.00117	0.00145	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00116	0.00144	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00116	0.00144	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00116	0.00144	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00116	0.00143	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	0.00111	0.00138	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.00111	0.00138	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00111	0.00137	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.0011	0.00137	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00109	0.00135	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00109	0.00135	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00107	0.00133	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00107	0.00132	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00104	0.00129	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00103	0.00128	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00101	0.00125	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.001	0.00124	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	0.000999	0.00124	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000996	0.00124	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	0.000991	0.00123	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000988	0.00123	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	0.000972	0.00121	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000968	0.0012	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000968	0.0012	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000964	0.0012	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PENK—Parkinson's disease	0.000947	0.00118	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAG—Parkinson's disease	0.000947	0.00118	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000944	0.00117	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000944	0.00117	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	0.000941	0.00117	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000938	0.00116	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000937	0.00116	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000937	0.00116	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000934	0.00116	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000934	0.00116	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000879	0.00109	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000876	0.00109	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	0.000866	0.00107	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000864	0.00107	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	0.000851	0.00106	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	0.000851	0.00106	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000848	0.00105	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000848	0.00105	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	0.000815	0.00101	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000812	0.00101	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	0.000805	0.000999	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000803	0.000996	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000752	0.000933	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	0.00075	0.000931	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000748	0.000928	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000715	0.000887	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000712	0.000884	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	0.000706	0.000876	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000704	0.000873	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000685	0.00085	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000683	0.000847	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	0.000681	0.000845	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000679	0.000843	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000656	0.000814	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000654	0.000812	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—INSR—Parkinson's disease	0.000632	0.000784	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.00063	0.000782	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGB—Parkinson's disease	0.000597	0.000741	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000596	0.000739	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000595	0.000739	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	0.000594	0.000737	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000594	0.000737	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000592	0.000735	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	0.000585	0.000726	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000583	0.000724	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	0.000574	0.000712	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000572	0.00071	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	0.000556	0.00069	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000554	0.000687	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000519	0.000644	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000517	0.000642	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	0.000503	0.000624	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	0.000503	0.000624	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000501	0.000622	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000501	0.000622	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	0.000421	0.000523	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.00042	0.000521	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	0.000407	0.000505	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000406	0.000504	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	0.000402	0.000499	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000401	0.000498	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NGF—Parkinson's disease	0.00037	0.000459	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000369	0.000457	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	0.000352	0.000437	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000351	0.000435	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—APOE—Parkinson's disease	0.000327	0.000406	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000326	0.000405	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—INS—Parkinson's disease	0.00028	0.000347	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.000279	0.000346	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	0.000208	0.000258	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000208	0.000257	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	0.000207	0.000257	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000206	0.000256	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	0.000191	0.000237	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000191	0.000237	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL6—Parkinson's disease	0.000122	0.000152	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	0.000122	0.000151	CbGpPWpGaD
